• linkedin
  • Increase Font
  • Sharebar

    Every New FDA Drug Approval in 2017

    The last 12 drugs approved in the year, along with the other 34.

     

    Hemlibra image

    Hemlibra (emicizumab-kxwh), Genentech

    Indications: Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors.

    Dosage: 3 mg/kg by subcutaneous injection once weekly for the first 4 weeks, followed by 1.5 mg/kg once weekly.

    Contraindications: None

    Click here to read more of our coverage

    Click here to read the full label

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available